Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-in-human single-dose escalation study of PF-06372865 in healthy adults
NL-OMON40275Phase 1Active, not recruiting
- Sponsor
- Pfizer
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of darigabat in chronic pain (4 arms), sponsored by Pfizer. Primary endpoints: Safety and tolerability, Pharmacokinetics of PF-06372865 and 7 more. Started Oct 2013; status: active, not recruiting.
02
Drugs
darigabat
03
Conditions
chronic pain
Beyond the preview
Go deeper on NL-OMON40275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40275.